Esperion Therapeutics Inc (ESPR) financials · rev $403.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Esperion Therapeutics Inc (ESPR) rev $403.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $403.1M | $332.3M |
| Operating Income | $60.3M | $54.4M |
| Net Income | -$22.7M | -$51.7M |
| EPS (Diluted) | -$0.11 | -$0.28 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $465.9M | $343.8M |
| Current Assets | $462.6M | $338.0M |
| Cash & Equivalents | $167.9M | $144.8M |
| Inventory | $105.1M | $94.5M |
| PP&E | $338.0K | $254.0K |
| Total Liabilities | $767.9M | $732.5M |
| Current Liabilities | $300.8M | $246.2M |
| Shareholders' Equity | -$302.0M | -$388.7M |
| Retained Earnings | -$1.62B | -$1.60B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$13.1M | -$23.7M |
| CapEx | N/A | $317.0K |
| Investing Cash Flow | N/A | -$317.0K |
| Financing Cash Flow | $36.2M | $86.5M |
| Net Change in Cash | $23.1M | $62.5M |
| Free Cash Flow | -$13.1M | -$24.0M |
FAQ
What is ESPR P/E and revenue?
Esperion Therapeutics Inc (ESPR) rev $403.1M.
What is ESPR revenue?
Esperion Therapeutics Inc last cached revenue is $403.1M (FY2025).
Is ESPR profitable?
Esperion Therapeutics Inc last cached net income is -$22.7M (FY2025).
What are ESPR total assets?
Esperion Therapeutics Inc last cached total assets are $465.9M (FY2025).
What is ESPR free cash flow?
Esperion Therapeutics Inc last cached free cash flow is -$13.1M (FY2025).
Not investment advice. Cached statements, not a live tape.